Form 483

Mi3 Limited Form 483, 2020-02-06

FDA issued a Form 483 to Mi3 Limited on 2020-02-06 with 4 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health4 observations

Mi3 Limited · Blackburn, United Kingdom · Issued February 6, 2020

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

6 Feb 2020
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Shaquenta Y Perkins

6 Feb 2020
21 CFR 820.250(b)

Sampling plans

Cited by Shaquenta Y Perkins

6 Feb 2020
21 CFR 820.30(g)

Design Validation - Risk analysis not performed/inadequate

Cited by Shaquenta Y Perkins

6 Feb 2020
21 CFR 820.75(a)

Lack of or inadequate process validation

Cited by Shaquenta Y Perkins

Inspected site

MLMi3 LimitedBlackburn, United Kingdom

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.250(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere